- Home
- IKNA vs UAMY Comparison
IKNA vs UAMY Comparison
Compare IKNA & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKNA
- UAMY
- Stock Information
- Founded
- IKNA 2016
- UAMY 1968
- Country
- IKNA United States
- UAMY United States
- Employees
- IKNA N/A
- UAMY N/A
- Industry
- IKNA Biotechnology: Pharmaceutical Preparations
- UAMY Metal Fabrications
- Sector
- IKNA Health Care
- UAMY Industrials
- Exchange
- IKNA Nasdaq
- UAMY Nasdaq
- Market Cap
- IKNA 80.8M
- UAMY 74.2M
- IPO Year
- IKNA 2021
- UAMY N/A
- Fundamental
- Price
- IKNA $1.71
- UAMY $0.71
- Analyst Decision
- IKNA Buy
- UAMY Strong Buy
- Analyst Count
- IKNA 2
- UAMY 1
- Target Price
- IKNA $3.00
- UAMY $1.00
- AVG Volume (30 Days)
- IKNA 60.6K
- UAMY 565.9K
- Earning Date
- IKNA 11-07-2024
- UAMY 11-12-2024
- Dividend Yield
- IKNA N/A
- UAMY N/A
- EPS Growth
- IKNA N/A
- UAMY N/A
- EPS
- IKNA N/A
- UAMY N/A
- Revenue
- IKNA $659,000.00
- UAMY $10,219,826.00
- Revenue This Year
- IKNA N/A
- UAMY N/A
- Revenue Next Year
- IKNA N/A
- UAMY N/A
- P/E Ratio
- IKNA N/A
- UAMY N/A
- Revenue Growth
- IKNA N/A
- UAMY 21.44
- 52 Week Low
- IKNA $1.22
- UAMY $0.17
- 52 Week High
- IKNA $2.32
- UAMY $0.82
- Technical
- Relative Strength Index (RSI)
- IKNA 49.85
- UAMY 57.35
- Support Level
- IKNA $1.71
- UAMY $0.49
- Resistance Level
- IKNA $1.77
- UAMY $0.75
- Average True Range (ATR)
- IKNA 0.05
- UAMY 0.06
- MACD
- IKNA -0.00
- UAMY 0.02
- Stochastic Oscillator
- IKNA 38.46
- UAMY 84.65
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.